share_log

The One-year Underlying Earnings Growth at Beijing Wandong Medical TechnologyLtd (SHSE:600055) Is Promising, but the Shareholders Are Still in the Red Over That Time

The One-year Underlying Earnings Growth at Beijing Wandong Medical TechnologyLtd (SHSE:600055) Is Promising, but the Shareholders Are Still in the Red Over That Time

北京万东医疗科技股份有限公司(SHSE: 600055)一年的基础收益增长令人鼓舞,但在此期间,股东仍处于亏损状态
Simply Wall St ·  03/27 15:21

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if you buy individual stocks, you can do both better or worse than that. That downside risk was realized by Beijing Wandong Medical Technology Co.,Ltd. (SHSE:600055) shareholders over the last year, as the share price declined 35%. That's well below the market decline of 13%. On the other hand, the stock is actually up 14% over three years.

被动投资指数基金是确保自己的回报与整个市场大致相匹配的好方法。但是,如果你买入个股,你的表现可能比这更好或更差。这种下行风险是由北京万东医疗科技有限公司实现的。由于股价下跌了35%,有限公司(上海证券交易所股票代码:600055)的股东。这远低于13%的市场跌幅。另一方面,股票实际上是 向上 三年内达到 14%。

With the stock having lost 4.8% in the past week, it's worth taking a look at business performance and seeing if there's any red flags.

由于该股在过去一周下跌了4.8%,值得看一下业务表现,看看是否存在任何危险信号。

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

引用巴菲特的话说:“船只将在世界各地航行,但Flat Earth Society将蓬勃发展。市场上的价格和价值之间将继续存在巨大差异...”通过比较每股收益(EPS)和一段时间内的股价变化,我们可以了解投资者对公司的态度是如何随着时间的推移而变化的。

During the unfortunate twelve months during which the Beijing Wandong Medical TechnologyLtd share price fell, it actually saw its earnings per share (EPS) improve by 1.1%. It's quite possible that growth expectations may have been unreasonable in the past.

在北京万东医疗科技有限公司股价下跌的不幸十二个月中,其每股收益(EPS)实际上增长了1.1%。过去的增长预期很可能不合理。

By glancing at these numbers, we'd posit that the the market had expectations of much higher growth, last year. But other metrics might shed some light on why the share price is down.

通过看一眼这些数字,我们假设市场预计去年会有更高的增长。但是其他指标可能会为股价下跌的原因提供一些启示。

With a low yield of 0.9% we doubt that the dividend influences the share price much. Beijing Wandong Medical TechnologyLtd managed to grow revenue over the last year, which is usually a real positive. Since we can't easily explain the share price movement based on these metrics, it might be worth considering how market sentiment has changed towards the stock.

由于收益率为0.9%,我们怀疑股息是否会对股价产生很大影响。去年,北京万东医疗科技有限公司成功实现了收入增长,这通常是一个真正的积极因素。由于我们无法根据这些指标轻松解释股价走势,因此可能值得考虑市场对该股的情绪发生了怎样的变化。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下图描述了收入和收入随时间推移而发生的变化(点击图片即可显示确切的数值)。

earnings-and-revenue-growth
SHSE:600055 Earnings and Revenue Growth March 27th 2024
SHSE: 600055 收益和收入增长 2024 年 3 月 27 日

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

您可以在这张免费的交互式图片中看到其资产负债表如何随着时间的推移而增强(或减弱)。

A Different Perspective

不同的视角

We regret to report that Beijing Wandong Medical TechnologyLtd shareholders are down 34% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 13%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Longer term investors wouldn't be so upset, since they would have made 1.9%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for Beijing Wandong Medical TechnologyLtd that you should be aware of before investing here.

我们遗憾地报告,北京万东医疗科技有限公司的股东今年下跌了34%(甚至包括股息)。不幸的是,这比整个市场13%的跌幅还要严重。话虽如此,在下跌的市场中,一些股票不可避免地会被超卖。关键是要密切关注基本发展。长期投资者不会那么沮丧,因为他们将在五年内每年赚1.9%。如果基本面数据继续显示长期可持续增长,那么当前的抛售可能是一个值得考虑的机会。尽管市场状况可能对股价产生的不同影响值得考虑,但还有其他因素更为重要。例如,我们发现了北京万东医疗科技有限公司的两个警告信号,在投资这里之前,你应该注意这些信号。

We will like Beijing Wandong Medical TechnologyLtd better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我们看到一些重大的内幕收购,我们会更喜欢北京万东医疗技术有限公司。在我们等待的同时,请查看这份免费清单,列出了最近有大量内幕收购的成长型公司。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发